Levy Adam Scott Insider Trading Activity

Corporate InsiderCFO · CIK 1693134

17

Total trades

$7.4M

Total volume

Jan 12, 2026

Last activity

MLYS

Mineralys Therapeutics, Inc.

Levy Adam Scott has been net-selling over the last 12 months with 0 purchases and 16 sales across 1 company.

MLYS is the most-traded position with 16 trades. The largest single transaction was a sale of MLYS for $1.8M on Nov 11, 2025.

Performance Scorecard

Forward stock performance after each transaction by Levy Adam Scott. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.

PERIODAVG BUY RETURNAVG SELL AVOIDEDSUCCESS RATETRADES
30 days+7.1%65%17
90 days-35.0%71%17
120 days-36.2%71%17

Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.

Price & Trades

Pro: Trade Markers

MLYS · Mineralys Therapeutics, Inc.

🔒 Subscribe to see trade entries

Pro members see exactly when Levy Adam Scott bought and sold MLYS.

Upgrade to Pro

Recent Trades

DATETICKERTYPESHARESPRICEVALUEΔ OWNEDROLEFILING
Jan 12, 2026
MLYSSell10,758$32.14$346K−55.5%CFO
Nov 11, 2025
MLYSSell1,015$42.00$43K−0.7%CFO
Nov 11, 2025
MLYSSell11,295$41.87$473K−8.2%CFO
Nov 11, 2025
MLYSSell1,561$42.68$67K−1.2%CFO
Nov 11, 2025
MLYSSell12,952$41.65$539K−10.4%CFO
Nov 11, 2025
MLYSSell8,485$42.34$359K−7.6%CFO
Nov 11, 2025
MLYSSell4,142$43.50$180K−4.0%CFO
Nov 11, 2025
MLYSSell8,456$45.18$382K−8.5%CFO
Nov 11, 2025
MLYSSell32,718$46.88$1.5M−62.8%CFO
Nov 11, 2025
MLYSSell38,900$45.93$1.8M−42.7%CFO
Oct 13, 2025
MLYSSell3,392$42.26$143K−2.8%CFO
Oct 13, 2025
MLYSSell7,366$41.90$309K−5.8%CFO
Jul 30, 2025
MLYSSell51,500$14.70$757K−26.7%CFO
Jul 30, 2025
MLYSSell8,425$15.10$127K−6.0%CFO
Jul 29, 2025
MLYSSell807$14.00$11K−0.4%CFO
Jul 28, 2025
MLYSSell12,946$14.04$182K−6.3%CFO
Jul 11, 2025
MLYSSell10,758$14.45$155K−4.9%CFO

Top Companies Traded

TICKERCOMPANYTRADESTOTAL VOLUME
MLYSMineralys Therapeutics, Inc.17$7.4M

Other insiders at Mineralys Therapeutics, Inc.

5 other tracked filers at MLYS.